U.S body says gene therapy may be more cost effective for spinal muscular atrophy

The findings may be revised based on comments from the drugmakers, health plans and patients before a final assessment in late February.

Original source: https://health.economictimes.indiatimes.com/news/pharma/u-s-body-says-gene-therapy-may-be-more-cost-effective-for-spinal-muscular-atrophy/67191190?utm_source=RSS&utm_medium=ETRSS

Related Posts